Targeting and vaccine durability are key for populationlevel impact and costeffectiveness of a poxprotein HIV vaccine regimen in South Africa

Simple item page
dc.citation.doi10.1016/J.VACCINE.2019.02.073
dc.citation.epage2267
dc.citation.spage2258
dc.contributor.authorChristian Selinger
dc.contributor.authorAnna Bershteyn
dc.contributor.authorDobromir Dimitrov
dc.contributor.authorBlythe J.S Adamson
dc.contributor.authorVera Rees
dc.contributor.authorGlenda Gray
dc.contributor.authorE et al
dc.date.accessioned2023-10-06T11:51:50Z
dc.date.available2023-10-06T11:51:50Z
dc.identifier.citationISI
dc.identifier.issn0264-410X
dc.identifier.urihttps://hdl.handle.net/10539/36375
dc.journal.titleVACCINE
dc.journal.volume37
dc.titleTargeting and vaccine durability are key for populationlevel impact and costeffectiveness of a poxprotein HIV vaccine regimen in South Africa
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal.pdf
Size:
933.54 KB
Format:
Adobe Portable Document Format
Description:
Journal
Download
Collections
Academic Wits Research Outputs (All submissions)